Profile data is unavailable for this security.
About the company
Well Lead Medical Co Ltd is a China-based company primarily engaged in the research and development, production, and sales of medical devices in the fields of anesthesia, catheterization, urology, nursing, respiration, and hemodialysis. The Company’s products include endotracheal intubation, laryngeal mask airway, bronchial intubation, urinary catheter, urinary catheterization bag, circumcision stapler, stone clearing sheath, minimally invasive dilation and drainage kit, Yangke drainage tube, mouth protection suction tube, oxygen mask, drug inhalation atomizer, blood purification extracorporeal circulation tub and others. The Company’s products are mainly used in surgery, minimally invasive surgery, emergency care, and nursing. The Company conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)1.64bn
- Net income in CNY244.31m
- Incorporated2004
- Employees2.76k
- LocationWell Lead Medical Co LtdNo. 47 ITC Avenue SouthHualong Town, Panyu DistrictGUANGZHOU 511434ChinaCHN
- Phone+86 2 039945995
- Fax+86 2 039945995
- Websitehttp://www.welllead.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Kindly Enterprise Dev Gp Co Ltd | 2.28bn | 243.83m | 4.08bn | 3.89k | 16.67 | 1.53 | -- | 1.79 | 0.5598 | 0.5598 | 5.22 | 6.11 | 0.5475 | 3.76 | 2.37 | 585,641.90 | 6.36 | 7.57 | 9.89 | 14.54 | 32.46 | 35.12 | 11.61 | 12.01 | 1.34 | -- | 0.176 | 25.53 | -7.79 | 4.47 | -6.75 | 4.83 | -8.09 | 0.00 |
| Shanghai ZJ Bio-Tech Co Ltd | 131.50m | -143.83m | 4.14bn | 285.00 | -- | 1.22 | -- | 31.49 | -0.7312 | -0.7312 | 0.6974 | 17.66 | 0.0344 | 0.5504 | 2.34 | 461,420.70 | -3.76 | 12.74 | -3.90 | 14.10 | 44.26 | 57.49 | -109.37 | 31.92 | 22.65 | -- | 0.0558 | 37.90 | -34.88 | -7.15 | 6.86 | -- | -3.72 | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 1.12bn | 102.20m | 4.30bn | 1.69k | 41.87 | 2.51 | -- | 3.83 | 0.466 | 0.466 | 5.13 | 7.78 | 0.5465 | 6.12 | 3.84 | 664,064.40 | 4.96 | 14.20 | 5.91 | 16.37 | 29.10 | 39.16 | 9.07 | 20.48 | 2.65 | -- | 0.0978 | 42.51 | 14.37 | 15.06 | 57.28 | 8.61 | 1.39 | -- |
| Nanjing Medlander Medical Tech Co Ltd | 437.82m | 101.51m | 4.34bn | 582.00 | 41.87 | 3.18 | -- | 9.92 | 1.04 | 1.04 | 4.47 | 13.68 | 0.2865 | 2.18 | 15.40 | 752,267.60 | 6.81 | 11.96 | 7.54 | 13.89 | 69.16 | 71.98 | 23.76 | 31.41 | 8.22 | -- | 0.0268 | 48.42 | 24.57 | 10.68 | 13.10 | -0.8601 | 23.21 | -- |
| Well Lead Medical Co Ltd | 1.64bn | 244.31m | 4.36bn | 2.76k | 18.03 | 2.25 | -- | 2.66 | 0.8288 | 0.8288 | 5.57 | 6.63 | 0.5811 | 4.75 | 6.81 | 593,586.30 | 9.07 | 8.23 | 11.07 | 10.15 | 42.85 | 43.50 | 15.61 | 13.60 | 1.39 | 82.37 | 0.2436 | 57.82 | 8.76 | 8.72 | 13.98 | 12.61 | 22.91 | 26.58 |
| Jianerkang Medical Co Ltd | 988.21m | 103.17m | 4.44bn | 1.64k | 17.85 | 3.04 | -- | 4.49 | 1.59 | 1.59 | 8.03 | 9.35 | 0.6961 | 4.54 | 4.50 | 603,301.80 | 7.27 | -- | 8.08 | -- | 23.15 | -- | 10.44 | -- | 7.07 | -- | 0.0146 | -- | 1.18 | -- | -2.69 | -- | -- | -- |
| Getein Biotech Inc | 1.04bn | 181.90m | 4.45bn | 1.95k | 24.48 | 1.65 | -- | 4.27 | 0.3587 | 0.3587 | 2.06 | 5.31 | 0.2683 | 1.68 | 2.68 | 535,523.10 | 4.41 | 10.90 | 6.31 | 15.53 | 67.54 | 64.96 | 16.43 | 25.58 | 2.14 | -- | 0.1839 | 31.15 | -14.93 | 3.77 | -20.06 | -8.02 | 4.62 | -2.48 |
| Chimin Health Management Co Ltd | 637.78m | -165.28m | 4.67bn | 1.99k | -- | 3.32 | -- | 7.32 | -0.3276 | -0.3276 | 1.24 | 2.67 | 0.2591 | 3.15 | 3.72 | 319,848.50 | -6.70 | 0.4271 | -9.09 | 0.6335 | 27.94 | 42.63 | -25.86 | 1.16 | 0.8238 | -8.24 | 0.3308 | 65.53 | -13.28 | 0.1151 | 8.81 | -- | -1.88 | -- |
Data as of Feb 06 2026. Currency figures normalised to Well Lead Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cinda Fund Management Co. Ltd.as of 30 Jun 2025 | 2.19m | 0.75% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.11m | 0.72% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.95m | 0.67% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 1.33m | 0.46% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 657.70k | 0.23% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 479.31k | 0.17% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 397.02k | 0.14% |
| VanEck Australia Pty Ltd.as of 08 Jan 2026 | 239.10k | 0.08% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2025 | 217.90k | 0.08% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 179.94k | 0.06% |
More ▼
Data from 30 Jun 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
